In Vitro Activities of MK-0826 and 16 Other Antimicrobials against Bacteroides fragilis Group Strains-Reference-Cited by-同舟云学术

In Vitro Activities of MK-0826 and 16 Other Antimicrobials against Bacteroides fragilis Group Strains

Published:2001-08 Issue:8 Volume:45 Page:2372-2374
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Betriu Carmen¹,Sánchez Ana¹,Palau Marı́a Luisa¹,Gómez Marı́a¹,Picazo Juan J.¹

Affiliation:

1. Department of Clinical Microbiology, Hospital Clı́nico San Carlos, 28040 Madrid, Spain

Abstract

ABSTRACT The activity of MK-0826, a new carbapenem, against 309 Bacteroides fragilis group strains was investigated and compared with that of 11 other β-lactam and 5 non-β-lactam agents. MK-0826 showed excellent activity (MICs ranged from ≤0.06 to 4 μg/ml). The new carbapenem may be useful in the treatment of mixed anaerobic infections involving B. fragilis group strains.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.45.8.2372-2374.2001

Reference14 articles.

1. A five-year multicenter study of the susceptibility of the Bacteroides fragilis group isolates to cephalosporins, cephamicins, penicillins, clindamycin, and metronidazole in the United States.;Aldridge K. E.;Diagn. Microbiol. Infect. Dis.,1994

2. Multicenter Survey of the Changing In Vitro Antimicrobial Susceptibilities of Clinical Isolates of Bacteroides fragilis Group, Prevotella, Fusobacterium, Porphyromonas , and Peptostreptococcus Species

3. Susceptibility patterns and resistance to imipenem in the Bacteroides fragilis group species in Japan: a 4-year study.;Bandoh K.;Clin. Infect. Dis.,1993

4. Changes in the susceptibility of Bacteroides fragilis group organisms to various antimicrobial agents.;Betriu C.;Eur. J. Clin. Microbiol. Infect. Dis.,1992

5. Activities of New Antimicrobial Agents (Trovafloxacin, Moxifloxacin, Sanfetrinem, and Quinupristin-Dalfopristin) against Bacteroides fragilis Group: Comparison with the Activities of 14 Other Agents

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Piperacillin–tazobactam: a β-lactam/β-lactamase inhibitor combination;Expert Review of Anti-infective Therapy;2007-06

2. Ertapenem: the new carbapenem 5 years after first FDA licensing for clinical practice;Expert Opinion on Pharmacotherapy;2007-01-26

3. Comparative in vitro activity and the inoculum effect of ertapenem against Enterobacteriaceae resistant to extended-spectrum cephalosporins;International Journal of Antimicrobial Agents;2006-07

4. Empiric Treatment of Nosocomial Intra-Abdominal Infections: A Focus on the Carbapenems;Surgical Infections;2005-09

5. In vitro activity of tigecycline against Bacteroides species;Journal of Antimicrobial Chemotherapy;2005-06-10